131 related articles for article (PubMed ID: 24709195)
21. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
22. Current status of cancer immunotherapy for esophageal squamous cell carcinoma.
Kono K; Mimura K; Yamada R; Ujiie D; Hayase S; Tada T; Hanayama H; Min AKT; Shibata M; Momma T; Saze Z; Ohki S
Esophagus; 2018 Jan; 15(1):1-9. PubMed ID: 29892809
[TBL] [Abstract][Full Text] [Related]
23. Exploring cell competition for the prevention and therapy of esophageal squamous cell carcinoma.
Knapp K; Verchio V; Coburn-Flynn O; Li Y; Xiong Z; Morrison JC; Shersher DD; Spitz F; Chen X
Biochem Pharmacol; 2023 Aug; 214():115639. PubMed ID: 37290594
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Zhang F; Wang Y; Wang ZQ; Sun P; Wang DS; Jiang YX; Zhang DS; Wang FH; Xu RH; Li YH
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868295
[TBL] [Abstract][Full Text] [Related]
25. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
[TBL] [Abstract][Full Text] [Related]
26. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Xia HH; Zhang ST; Lam SK; Lin MC; Kung HF; Wong BC
Carcinogenesis; 2005 Jan; 26(1):11-5. PubMed ID: 15358635
[TBL] [Abstract][Full Text] [Related]
27. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
[TBL] [Abstract][Full Text] [Related]
28. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Wang SQ; Wang X; Zheng K; Liu KS; Wang SX; Xie CH
Biochem Biophys Res Commun; 2017 Nov; 493(1):534-541. PubMed ID: 28867195
[TBL] [Abstract][Full Text] [Related]
30. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
31. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
[TBL] [Abstract][Full Text] [Related]
32. Deleterious effects of prostaglandin E2 in oesophageal carcinogenesis.
Morgan G
Med Hypotheses; 1997 Feb; 48(2):177-81. PubMed ID: 9076700
[TBL] [Abstract][Full Text] [Related]
33. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma.
Tang Q; Li G; Wei X; Zhang J; Chiu JF; Hasenmayer D; Zhang D; Zhang H
Cancer Lett; 2013 Aug; 336(2):325-37. PubMed ID: 23541682
[TBL] [Abstract][Full Text] [Related]
35. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
Liu X; Yan Y; Ma W; Wu S
Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
[TBL] [Abstract][Full Text] [Related]
37. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
38. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.
Choi S; Cui C; Luo Y; Kim SH; Ko JK; Huo X; Ma J; Fu LW; Souza RF; Korichneva I; Pan Z
FASEB J; 2018 Jan; 32(1):404-416. PubMed ID: 28928244
[TBL] [Abstract][Full Text] [Related]
40. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
